▼ SELL
10b5-1 Plan
$ Value
$15K
Shares
1,616
Price
$10
Filed
Feb 26
Insider
Name
Eisner Mark
Title
EVP and Chief Medical Officer
CIK
0001834161
Roles
Officer
Transaction Details
Transaction Date
2026-02-24
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
155,913
Footnotes
Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.
Filing Info
Eisner Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-25 | VIR | ▼ | $19K |
| 2026-02-24 | VIR | ▼ | $15K |
| 2026-02-23 | VIR | ▼ | $16K |
| 2026-02-22 | VIR | A | $0 |
| 2026-02-22 | VIR | A | $0 |
| 2026-02-21 | ZURA | A | $0 |
| 2025-07-17 | VIR | ▼ | $20K |
| 2025-07-15 | VIR | ▼ | $37K |
Other Insiders at VIR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SATO VICKI L | — | $992K | 2026-04-01 |
|
De Backer Marianne
Chief Executive Officer
|
— | $283K | 2026-02-24 |
|
De Backer Marianne
President and CEO
|
— | $664K | 2026-04-06 |
|
Eisner Mark
EVP and Chief Medical Officer
|
— | $34K | 2026-02-25 |
|
O'Byrne Jason
EVP & Chief Financial Officer
|
— | $31K | 2026-03-20 |
|
de Verneuil Vanina
EVP, General Counsel, Corp Sec
|
— | $197K | 2026-02-25 |
|
Sabatini Brent
SVP, Chief Accounting Officer
|
— | $110K | 2026-03-23 |